A Network Analysis of Multiple Myeloma Related Gene Signatures.

Bayesian network gene signature multiple myeloma prognostic treatment response

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Sep 2019
Historique:
received: 31 07 2019
revised: 20 09 2019
accepted: 20 09 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 2 10 2019
Statut: epublish

Résumé

Multiple myeloma (MM) is the second most prevalent hematological cancer. MM is a complex and heterogeneous disease, and thus, it is essential to leverage omics data from large MM cohorts to understand the molecular mechanisms underlying MM tumorigenesis, progression, and drug responses, which may aid in the development of better treatments. In this study, we analyzed gene expression, copy number variation, and clinical data from the Multiple Myeloma Research Consortium (MMRC) dataset and constructed a multiple myeloma molecular causal network (M3CN). The M3CN was used to unify eight prognostic gene signatures in the literature that shared very few genes between them, resulting in a prognostic subnetwork of the M3CN, consisting of 178 genes that were enriched for genes involved in cell cycle (fold enrichment = 8.4,

Identifiants

pubmed: 31569720
pii: cancers11101452
doi: 10.3390/cancers11101452
pmc: PMC6827160
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : U01 HG008451
Pays : United States

Références

Sci Rep. 2017 Apr 4;7(1):641
pubmed: 28377632
Epigenetics. 2011 Aug;6(8):1047-52
pubmed: 21934357
J Biol Chem. 2000 Mar 3;275(9):6276-83
pubmed: 10692424
Blood Cancer J. 2015 Dec 04;5:e373
pubmed: 26636288
Leukemia. 2018 Feb;32(2):383-390
pubmed: 28761118
PLoS Biol. 2012;10(4):e1001301
pubmed: 22509135
Sci Rep. 2017 Sep 5;7(1):10570
pubmed: 28874807
Leukemia. 2010 Jan;24(1):22-32
pubmed: 19907437
Gigascience. 2019 Jul 1;8(7):
pubmed: 31289834
Blood. 2018 Aug 9;132(6):587-597
pubmed: 29884741
Cancer Res. 1995 Sep 1;55(17):3854-9
pubmed: 7641204
Annu Rev Pharmacol Toxicol. 2005;45:465-76
pubmed: 15822185
Blood. 2004 Aug 15;104(4):1151-8
pubmed: 15105292
Leukemia. 2012 Nov;26(11):2406-13
pubmed: 22722715
Leukemia. 2014 Dec;28(12):2410-3
pubmed: 25079174
Leukemia. 2019 Jan;33(1):159-170
pubmed: 29967379
Am J Hematol. 2016 Oct;91(10):E442-7
pubmed: 27420405
Clin Trials. 2018 Jun;15(3):278-285
pubmed: 29638145
J Urol. 2007 Oct;178(4 Pt 1):1245-8
pubmed: 17698125
Leuk Lymphoma. 2008 Mar;49(3):559-69
pubmed: 18297535
PLoS Comput Biol. 2014 Aug 14;10(8):e1003790
pubmed: 25122495
Front Endocrinol (Lausanne). 2016 Jun 17;7:67
pubmed: 27379019
J Comput Biol. 2000;7(3-4):601-20
pubmed: 11108481
J Clin Invest. 2010 Jul;120(7):2414-22
pubmed: 20577049
Clin Cancer Res. 2011 May 15;17(10):3259-71
pubmed: 21430070
Blood. 2010 Oct 7;116(14):2543-53
pubmed: 20574050
J Clin Oncol. 2005 Oct 10;23(29):7296-306
pubmed: 16129847
Leukemia. 2018 Jan;32(1):120-130
pubmed: 28642592
Nat Commun. 2018 Jul 27;9(1):2943
pubmed: 30054467
Blood Cancer J. 2017 Jun 30;7(6):e581
pubmed: 28665416
Blood. 2007 Apr 15;109(8):3489-95
pubmed: 17209057
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Leukemia. 2014 Feb;28(2):269-77
pubmed: 23974982
Mayo Clin Proc. 2004 Jul;79(7):867-74
pubmed: 15244382
Blood. 2007 Feb 15;109(4):1692-700
pubmed: 17023574
J Med Biochem. 2017 Apr 22;36(2):107-112
pubmed: 28680353
PLoS One. 2013;8(3):e58809
pubmed: 23554930
Leukemia. 2017 Aug;31(8):1706-1714
pubmed: 27909306
PLoS Comput Biol. 2007 Apr 13;3(4):e69
pubmed: 17432931
Anticancer Res. 2006 Mar-Apr;26(2A):953-9
pubmed: 16619492
Leukemia. 2018 Dec;32(12):2626-2635
pubmed: 29749396
Curr Protoc Bioinformatics. 2014 Sep 08;47:8.13.1-24
pubmed: 25199793
Curr Pharm Biotechnol. 2009 Apr;10(3):345-6
pubmed: 19355944
Blood. 2002 Mar 1;99(5):1745-57
pubmed: 11861292
Leukemia. 2016 May;30(5):1071-8
pubmed: 26669975
Front Immunol. 2018 Jun 04;9:1228
pubmed: 29915586
Oncotarget. 2016 Oct 18;7(42):68688-68707
pubmed: 27626693
Nat Rev Cancer. 2002 Mar;2(3):175-87
pubmed: 11990854
Blood. 2006 Sep 15;108(6):2020-8
pubmed: 16728703
Nat Genet. 2008 Jul;40(7):854-61
pubmed: 18552845
Biomed Res Int. 2014;2014:209670
pubmed: 24987674
ACS Chem Biol. 2015 Nov 20;10(11):2589-97
pubmed: 26322624
Nat Med. 2018 Dec;24(12):1867-1876
pubmed: 30523328
Nat Biotechnol. 2012 Aug;30(8):777-82
pubmed: 22820318
Mol Cancer Ther. 2012 Dec;11(12):2685-92
pubmed: 23087257
Haematologica. 2016 Apr;101(4):396-406
pubmed: 27033237
Clin Cancer Res. 2011 Jul 1;17(13):4309-19
pubmed: 21565982
Blood Cancer J. 2019 Jan 3;9(1):2
pubmed: 30607001
Hum Pathol. 2003 Jan;34(1):41-7
pubmed: 12605365
Blood. 2003 Feb 1;101(3):1128-40
pubmed: 12393520
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):518-524
pubmed: 29222300
Blood. 2011 Sep 29;118(13):3512-24
pubmed: 21628408
Blood. 2014 Jul 24;124(4):536-45
pubmed: 24914135
Nat Med. 2007 Jul;13(7):820-7
pubmed: 17589519
Mol Cell. 2011 Nov 18;44(4):609-20
pubmed: 22099308
Blood. 2007 Mar 15;109(6):2276-84
pubmed: 17105813
Blood. 2019 Jul 4;134(1):30-43
pubmed: 31023703
Oncotarget. 2014 May 15;5(9):2487-98
pubmed: 24809299
Nat Rev Clin Oncol. 2018 Jul;15(7):409-421
pubmed: 29686421
Blood. 2015 Oct 22;126(17):1996-2004
pubmed: 26330243
Biomarkers. 2013 Aug;18(5):436-45
pubmed: 23829492
Clin Cancer Res. 2016 Nov 15;22(22):5434-5442
pubmed: 28151711
Nature. 2011 Mar 24;471(7339):467-72
pubmed: 21430775
Lancet Haematol. 2017 Sep;4(9):e443-e451
pubmed: 28863804
Clin Cancer Res. 2016 Aug 15;22(16):4039-44
pubmed: 26847058
N Engl J Med. 2017 Apr 6;376(14):1311-1320
pubmed: 28379796
Br J Haematol. 2011 Feb;152(4):420-32
pubmed: 21223249
Nat Commun. 2019 Apr 23;10(1):1911
pubmed: 31015454
Blood. 2019 Mar 14;133(11):1217-1221
pubmed: 30692124
Oncotarget. 2016 Mar 1;7(9):9666-79
pubmed: 26575327
BMC Syst Biol. 2011 Aug 01;5:121
pubmed: 21806811
Genes Chromosomes Cancer. 2009 Jul;48(7):603-14
pubmed: 19396863
Bioinformatics. 2013 May 1;29(9):1149-57
pubmed: 23493321
Leukemia. 2018 Dec;32(12):2604-2616
pubmed: 29789651
Am J Clin Pathol. 2010 Sep;134(3):466-70
pubmed: 20716804
Blood. 2003 Feb 15;101(4):1520-9
pubmed: 12393535
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Blood. 2007 Apr 15;109(8):3177-88
pubmed: 17185464
Lancet. 2017 Feb 4;389(10068):519-527
pubmed: 28017406
Leukemia. 2017 Jun;31(6):1363-1367
pubmed: 28017969
Clin Cancer Res. 2010 Mar 15;16(6):1856-64
pubmed: 20215539
Blood. 2006 Sep 1;108(5):1724-32
pubmed: 16705089
Hematology Am Soc Hematol Educ Program. 2005;:346-52
pubmed: 16304402
Nat Rev Cancer. 2011 Jul 07;11(8):558-72
pubmed: 21734724
Nat Rev Clin Oncol. 2017 Feb;14(2):100-113
pubmed: 27531699
Blood. 2011 Feb 10;117(6):2009-11
pubmed: 20962323
Blood. 2018 Nov 15;132(20):2154-2165
pubmed: 30181174
J Clin Oncol. 2008 Oct 10;26(29):4798-805
pubmed: 18591550
Clin Cancer Res. 2008 Aug 1;14(15):4821-9
pubmed: 18676754
Haematologica. 2011 Jan;96(1):87-95
pubmed: 20884712
Nature. 2006 Nov 23;444(7118):444-54
pubmed: 17122850
Leukemia. 2019 Jun;33(6):1475-1486
pubmed: 30573782

Auteurs

Yu Liu (Y)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA.

Haocheng Yu (H)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA.

Seungyeul Yoo (S)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Eunjee Lee (E)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Alessandro Laganà (A)

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Samir Parekh (S)

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Eric E Schadt (EE)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Li Wang (L)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

Jun Zhu (J)

Sema4, a Mount Sinai Venture, 333 Ludlow St., Stamford, CT 06902, USA. jun.zhu@mssm.edu.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA. jun.zhu@mssm.edu.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA. jun.zhu@mssm.edu.

Classifications MeSH